Iepsen, Eva W.

GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women

Iepsen, E. W., Lundgren, J. R., Hartmann, B., Pedersen, O., Hansen, T., Jørgensen, N. R., Jensen, J.-E. B., Holst, J. J., Madsbad, S., & Torekov, S. S. (2015) · The Journal of Clinical Endocrinology & Metabolism

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 193

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist

Iepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J.-C., & Torekov, S. S. (2018) · Cell Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 156

Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

Iepsen, E. W., Lundgren, J., Dirksen, C., Jensen, J.-E., Pedersen, O., Hansen, T., Madsbad, S., Holst, J. J., & Torekov, S. S. (2015) · International Journal of Obesity

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 118

Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36

Iepsen, E. W., Lundgren, J., Holst, J. J., Madsbad, S., & Torekov, S. S. (2016) · European Journal of Endocrinology

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 101

KCNQ1 Long QT Syndrome Patients Have Hyperinsulinemia and Symptomatic Hypoglycemia

Torekov, S. S., Iepsen, E., Christiansen, M., Linneberg, A., Pedersen, O., Holst, J. J., Kanters, J. K., & Hansen, T. (2014) · Diabetes

Cardiac electrophysiology and arrhythmiasPancreatic function and diabetes

Cited by 84

Therapies for inter-relating diabetes and obesity – GLP-1 and obesity

Iepsen, E. W., Torekov, S. S., & Holst, J. J. (2014) · Expert Opinion on Pharmacotherapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 43

GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report

Iepsen, E. W., Have, C. T., Veedfald, S., Madsbad, S., Holst, J. J., Grarup, N., Pedersen, O., Brandslund, I., Holm, J.-C., Hansen, T., et al. (2020) · Cell Reports Medicine

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 43

Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity

Christensen, B. J., Iepsen, E. W., Lundgren, J., Holm, L., Madsbad, S., Holst, J. J., & Torekov, S. S. (2017) · Obesity Facts

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 28

Major rapid weight loss induces changes in cardiac repolarization

Vedel-Larsen, E., Iepsen, E. W., Lundgren, J., Graff, C., Struijk, J. J., Hansen, T., Holst, J. J., Madsbad, S., Torekov, S., & Kanters, J. K. (2016) · Journal of Electrocardiology

Cardiac electrophysiology and arrhythmiasCardiovascular Effects of Exercise

Cited by 17

Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass

Iepsen, E. W., Zhang, J., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Jørgensen, N. R., Holm, J.-C., & Torekov, S. S. (2020) · Journal of Bone and Mineral Metabolism

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 15